LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation.

MLA

C, Felder C., et al. “LY320135, a Novel Cannabinoid CB1 Receptor Antagonist, Unmasks Coupling of the CB1 Receptor to Stimulation of CAMP Accumulation.” The Journal of Pharmacology and Experimental Therapeutics, vol. 284, no. 1, Jan. 1998, pp. 291–97. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs5546639&authtype=sso&custid=ns315887.

APA

C, F. C., E, J. K., M, B. E., M, G., P, M. K., J, F. K., J, C. G., C, H. D., W, J. D., O, C. M., A, K. G., & M, B. (1998). LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. The Journal of Pharmacology and Experimental Therapeutics, 284(1), 291–297.

Chicago

C, Felder C, Joyce K E, Briley E M, Glass M, Mackie K P, Fahey K J, Cullinan G J, et al. 1998. “LY320135, a Novel Cannabinoid CB1 Receptor Antagonist, Unmasks Coupling of the CB1 Receptor to Stimulation of CAMP Accumulation.” The Journal of Pharmacology and Experimental Therapeutics 284 (1): 291–97. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs5546639&authtype=sso&custid=ns315887.